Hepatitis C (HCV) co-infection poses a significant health challenge for men who have sex with men (MSM) living with human immunodeficiency virus (HIV), with a global prevalence of 7%, far surpassing the 1% seen in the general population. This vulnerability stems from shared transmission routes, stigma, and structural barriers like poverty and limited healthcare access. While direct-acting antivirals (DAAs) offer a highly effective cure, inequities persist in accessing these therapies. Limited coverage by the AIDS Drug Assistance Program (ADAP) and restrictive state policies exacerbate disparities, leaving many without life-saving treatment.

Beyond policy reform, tailored interventions are essential to meet the unique needs of MSM living with HIV. These include targeted HCV screening, robust linkage to care, peer support programs to address stigma, and provider training to promote harm reduction and patient-centered care. Addressing these barriers requires mandating DAA coverage for all ADAPs, streamlining prior authorizations, increasing ADAP funding, and expanding financial assistance programs to ensure timely access to care.

Reference: Manint T. Addressing the High Burden of HCV in HIV-Positive MSM. HIV/HCV Co-Infection Watch. Accessed December 17, 2024. https://www.hiv-hcv-watch.com/blog/july-15-2024